Free Trial

Heart Test Laboratories (HSCS) Competitors

Heart Test Laboratories logo
$2.96 +0.05 (+1.72%)
Closing price 03:58 PM Eastern
Extended Trading
$3.00 +0.04 (+1.35%)
As of 07:22 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

HSCS vs. BSGM, SSKN, LYRA, NURO, WOK, LUCY, IINN, PAVM, MHUA, and POAI

Should you be buying Heart Test Laboratories stock or one of its competitors? The main competitors of Heart Test Laboratories include BioSig Technologies (BSGM), STRATA Skin Sciences (SSKN), Lyra Therapeutics (LYRA), NeuroMetrix (NURO), WORK Medical Technology Group LTD Ordinary Shares (WOK), Innovative Eyewear (LUCY), Inspira Technologies Oxy B.H.N. (IINN), PAVmed (PAVM), Meihua International Medical Technologies (MHUA), and Predictive Oncology (POAI). These companies are all part of the "medical equipment" industry.

Heart Test Laboratories vs.

Heart Test Laboratories (NASDAQ:HSCS) and BioSig Technologies (NASDAQ:BSGM) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, profitability, risk, institutional ownership, community ranking, media sentiment, analyst recommendations and dividends.

Heart Test Laboratories has a beta of 2.77, meaning that its share price is 177% more volatile than the S&P 500. Comparatively, BioSig Technologies has a beta of 0.43, meaning that its share price is 57% less volatile than the S&P 500.

Heart Test Laboratories has higher earnings, but lower revenue than BioSig Technologies.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Heart Test Laboratories$14.70K217.67-$6.61M-$7.48-0.40
BioSig Technologies$39K218.22-$29.04MN/AN/A

17.2% of Heart Test Laboratories shares are held by institutional investors. Comparatively, 7.2% of BioSig Technologies shares are held by institutional investors. 1.8% of Heart Test Laboratories shares are held by company insiders. Comparatively, 17.0% of BioSig Technologies shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Heart Test Laboratories had 6 more articles in the media than BioSig Technologies. MarketBeat recorded 6 mentions for Heart Test Laboratories and 0 mentions for BioSig Technologies. Heart Test Laboratories' average media sentiment score of 0.33 beat BioSig Technologies' score of 0.00 indicating that Heart Test Laboratories is being referred to more favorably in the media.

Company Overall Sentiment
Heart Test Laboratories Neutral
BioSig Technologies Neutral

BioSig Technologies received 97 more outperform votes than Heart Test Laboratories when rated by MarketBeat users. However, 85.71% of users gave Heart Test Laboratories an outperform vote while only 70.55% of users gave BioSig Technologies an outperform vote.

CompanyUnderperformOutperform
Heart Test LaboratoriesOutperform Votes
6
85.71%
Underperform Votes
1
14.29%
BioSig TechnologiesOutperform Votes
103
70.55%
Underperform Votes
43
29.45%

Heart Test Laboratories has a net margin of 0.00% compared to BioSig Technologies' net margin of -44,832.50%. BioSig Technologies' return on equity of 0.00% beat Heart Test Laboratories' return on equity.

Company Net Margins Return on Equity Return on Assets
Heart Test LaboratoriesN/A -117.76% -84.09%
BioSig Technologies -44,832.50%N/A -776.49%

Heart Test Laboratories currently has a consensus target price of $13.00, suggesting a potential upside of 339.19%. BioSig Technologies has a consensus target price of $2.75, suggesting a potential upside of 456.91%. Given BioSig Technologies' higher possible upside, analysts plainly believe BioSig Technologies is more favorable than Heart Test Laboratories.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Heart Test Laboratories
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
BioSig Technologies
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

Heart Test Laboratories beats BioSig Technologies on 9 of the 15 factors compared between the two stocks.

Remove Ads
Get Heart Test Laboratories News Delivered to You Automatically

Sign up to receive the latest news and ratings for HSCS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HSCS vs. The Competition

MetricHeart Test LaboratoriesSurgical appliances & supplies IndustryMedical SectorNASDAQ Exchange
Market Cap$3.20M$9.03B$5.74B$8.28B
Dividend YieldN/A1.41%4.55%4.02%
P/E Ratio-0.3717.6524.7019.36
Price / Sales217.6769.74396.6193.26
Price / CashN/A19.6738.1634.64
Price / Book0.275.657.154.51
Net Income-$6.61M$284.66M$3.20B$247.14M
7 Day Performance-2.95%-0.13%1.84%2.69%
1 Month Performance-19.54%-5.13%5.79%-3.39%
1 Year Performance-75.33%-19.11%15.10%5.06%

Heart Test Laboratories Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HSCS
Heart Test Laboratories
3.0518 of 5 stars
$2.96
+1.7%
$13.00
+339.2%
-75.8%$3.20M$14,700.00-0.3710Analyst Revision
News Coverage
Gap Up
BSGM
BioSig Technologies
1.2885 of 5 stars
$0.68
+11.5%
$2.75
+302.0%
+2.0%$11.79M$39,000.000.0050Positive News
Gap Up
SSKN
STRATA Skin Sciences
2.9567 of 5 stars
$2.63
-5.4%
$6.00
+128.1%
-46.2%$10.97M$32.68M-0.99120Upcoming Earnings
News Coverage
Gap Down
LYRA
Lyra Therapeutics
3.2532 of 5 stars
$0.17
-4.1%
$4.50
+2,627.3%
-97.2%$10.80M$1.47M-0.1150
NURO
NeuroMetrix
0.1548 of 5 stars
$4.41
+0.9%
N/A+8.7%$9.05M$3.77M-0.9620
WOK
WORK Medical Technology Group LTD Ordinary Shares
N/A$0.62
-3.1%
N/AN/A$9.05M$11.51M0.00226Positive News
Gap Down
LUCY
Innovative Eyewear
2.5648 of 5 stars
$3.69
-0.8%
$20.00
+442.0%
-39.6%$9.01M$1.56M-0.389Earnings Report
Gap Up
IINN
Inspira Technologies Oxy B.H.N.
0.5307 of 5 stars
$0.71
-2.7%
N/A-55.5%$8.96MN/A0.0020
PAVM
PAVmed
4.0009 of 5 stars
$0.76
+15.7%
$19.00
+2,388.2%
-62.7%$8.45M$4.03M-0.1890Upcoming Earnings
High Trading Volume
MHUA
Meihua International Medical Technologies
0.3803 of 5 stars
$0.34
+6.7%
N/A-56.2%$8.43M$94.25M0.00620Positive News
POAI
Predictive Oncology
1.8322 of 5 stars
$1.16
+3.6%
$3.00
+158.6%
-58.4%$7.67M$1.48M-0.3830Upcoming Earnings
Positive News
Remove Ads

Related Companies and Tools


This page (NASDAQ:HSCS) was last updated on 3/24/2025 by MarketBeat.com Staff
From Our Partners